Biosimilars to Experience Growth as Customers Seek Low Cost Biologics
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report.
The report “Specialty Physicians Discuss their Opinions of the United States Biosimilars Market” provides insights into the potential reactions of key customers and influence on biosimilars market uptake.
According to the 110 page report, biosimilars appearing on the horizon in theU.S.market, specialty physicians are seeking clinical data on their efficacy on various patient types. While cost is a significant adoption driver, physicians are more concerned about the safety and efficacy data including testing in specific patient populations, and reputation of the manufacturer.
Specialty physicians' initial acceptance of biosimilars and biobetters will depend heavily on strong clinical data and positive real-world experience. Physicians generally agreed that biosimilars produced by companies with a strong track record of producing high-quality products in the biologics sector will be accepted far more enthusiastically than those from companies that lack experience in developing and manufacturing biologics.
Find more reports about the Biosimilars market at Reportbuyer.com the online store for global business information. The website now lists more than 200,000 company overviews, market research reports, industry studies and business books from over 300 specialist publishers. Thousands of professionals from across the world make ReportBuyer.com their first choice in their search for quality business insight.
press@reportbuyer.com
t. 44 (0) 20 7060 7474
Report Buyer the online store for global business information. The website now lists more than 200,000 company overviews, market research reports, industry studies and business books from over 300 specialist publishers. Thousands of professionals from across the world make ReportBuyer.com their first choice in their search for quality business insight.
Tags: